PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
22 mars 2021 16h01 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical...
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
24 févr. 2021 06h04 HE
|
PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
04 févr. 2021 13h01 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25,...
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
17 déc. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ：PRAH）今天宣布任命Isaac...
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA 헬스사이언스, 새롭게 건립하는 Global Center of Excellence for Decentralized Clinical Trial Strategy 총괄할 FDA 고위 인사 영입
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ: PRAH))는 아이잭 로드리게스-차베스(Isaac Rodriguez-Chavez) 박사(공중보건학 석사, 이학 석사)를 과학, 임상 담당 부사장으로 선임한다고 발표했다....
PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) gab heute die Ernennung von Isaac Rodriguez-Chavez, PhD, MHS, MS, zum Senior Vice President, Scientific and...
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...